- Report
- March 2024
- 199 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- September 2023
- 135 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 250 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- August 2023
- 262 Pages
Global
From €4010EUR$4,175USD£3,452GBP
- Report
- May 2024
- 173 Pages
Global
From €5235EUR$5,450USD£4,507GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- November 2023
- 182 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- November 2023
- 148 Pages
Global
From €4274EUR$4,450USD£3,680GBP
- Report
- October 2023
- 145 Pages
Global
From €3025EUR$3,150USD£2,605GBP
- Report
- November 2023
- 216 Pages
Global
From €3458EUR$3,600USD£2,977GBP
- Report
- October 2023
- 85 Pages
United States
From €4562EUR$4,750USD£3,928GBP
- Report
- April 2020
Global
From €4754EUR$4,950USD£4,093GBP
- Report
- June 2022
- 135 Pages
Global
From €2161EUR$2,250USD£1,861GBP
- Book
- March 2021
- 400 Pages
From €158EUR$165USD£136GBP
- Report
- September 2019
- 63 Pages
Global
From €4754EUR$4,950USD£4,093GBP
The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more